A photo of Kelli Dominick.

Kelli C. Dominick, MD, PhD


  • Psychiatrist, Division of Child and Adolescent Psychiatry
  • Assistant Professor, UC Department of Psychiatry and Behavioral Neuroscience
  • Board Certified

About

Biography

Kelli Dominick, MD, PhD, is an assistant professor for the Division of Psychiatry at Cincinnati Children’s Hospital Medical Center who specializes in the clinical care and research in neurodevelopmental disorders including Autism Spectrum Disorder and Fragile X Syndrome. Dr. Dominick received her undergraduate degree in Biology and Psychology at Transylvania University. She then earned her MD and PhD degrees at Boston University School of Medicine where she was awarded a pre-doctoral fellowship (F30 NRSA) from the National Institutes of Health. She completed a combined residency program in pediatrics, adult and child psychiatry at Cincinnati Children’s Hospital Medical Center.

Dr. Dominick’s research interests include the use of neuroimaging to examine neural development, early identification and treatment of autism spectrum disorder and Fragile X Syndrome.

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Systematic Review: Emotion Dysregulation in Syndromic Causes of Intellectual and Developmental Disabilities. Shaffer, RC; Reisinger, DL; Schmitt, LM; Lamy, M; Dominick, KC; Smith, EG; Coffman, MC; Esbensen, AJ. Journal of the American Academy of Child and Adolescent Psychiatry. 2022.

Brief Report: Telehealth Satisfaction Among Caregivers of Pediatric and Adult Psychology and Psychiatry Patients with Intellectual and Developmental Disability in the Wake of Covid-19. Rosen, V; Blank, E; Lampert, E; Dominick, K; Will, M; Erickson, C; Pedapati, E; Lamy, M; Shaffer, R. Journal of Autism and Developmental Disorders. 2022.

Children with ASD establish joint attention during free-flowing toy play without face looks. Yurkovic-Harding, J; Lisandrelli, G; Shaffer, RC; Dominick, KC; Pedapati, EV; Erickson, CA; Yu, C; Kennedy, DP. Current Biology. 2022; 32:2739-2746.e4.

A Collaborative Psychiatric-Genetics Inpatient Care Delivery Model Improves Access to Clinical Genetic Evaluation, Testing, and Diagnosis for Patients With Neurodevelopmental Disorders. Shillington, A; Lamy, M; Dominick, KC; Sorter, M; Erickson, CA; Hopkin, R. Frontiers in Genetics. 2022; 13.

Evidence for Three Subgroups of Female FMR1 Premutation Carriers Defined by Distinct Neuropsychiatric Features: A Pilot Study. Schmitt, LM; Dominick, KC; Liu, R; Pedapati, EV; Ethridge, LE; Smith, E; Sweeney, JA; Erickson, CA. Frontiers in Integrative Neuroscience. 2022; 15.

Using head-mounted eye tracking to examine visual and manual exploration during naturalistic toy play in children with and without autism spectrum disorder. Yurkovic, JR; Lisandrelli, G; Shaffer, RC; Dominick, KC; Pedapati, EV; Erickson, CA; Kennedy, DP; Yu, C. Scientific Reports. 2021; 11.

Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder. Henneberry, E; Lamy, M; Dominick, KC; Erickson, CA. Journal of Autism and Developmental Disorders. 2021; 51:4370-4394.

Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. Dominick, KC; Andrews, HF; Kaufmann, WE; Berry-Kravis, E; Erickson, CA. Journal of Child and Adolescent Psychopharmacology. 2021; 31:659-669.

Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study. Budimirovic, DB; Dominick, KC; Gabis, LV; Adams, M; Adera, M; Huang, L; Ventola, P; Tartaglia, NR; Berry-Kravis, E. Frontiers in Pharmacology. 2021; 12.

Letter to the Editor: Chlorpromazine-Induced Skin Pigmentation in a Pediatric Patient. Harris, K; Lamy, M; Sorter, M; Frye, C; Terhune, L; Erickson, CA; Ruschman, G; Dominick, KC. Journal of Child and Adolescent Psychopharmacology. 2021; 31:516-517.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey